LIPG
Basic information
Region (hg38): 18:49560699-49599185
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LIPG gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 32 | 36 | ||||
missense | 51 | 64 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 3 | |||||
splice region | 1 | 4 | 1 | 6 | ||
non coding | 12 | |||||
Total | 0 | 0 | 58 | 43 | 16 |
Variants in LIPG
This is a list of pathogenic ClinVar variants found in the LIPG region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
18-49562308-G-T | LIPG-related disorder | Likely benign (Aug 29, 2019) | ||
18-49562320-C-A | Benign (Jan 31, 2024) | |||
18-49562344-C-T | Likely benign (Aug 19, 2023) | |||
18-49562371-C-T | Benign (Jan 31, 2024) | |||
18-49562377-A-C | Likely benign (Oct 17, 2021) | |||
18-49562378-C-T | not specified | Uncertain significance (Dec 13, 2022) | ||
18-49562384-G-A | Benign (Jan 31, 2024) | |||
18-49562419-G-A | Likely benign (Oct 14, 2022) | |||
18-49565330-A-C | Uncertain significance (Oct 04, 2023) | |||
18-49565334-A-C | Benign (Dec 26, 2023) | |||
18-49565335-A-C | not specified | Uncertain significance (Nov 29, 2023) | ||
18-49565352-G-A | Uncertain significance (Apr 28, 2021) | |||
18-49565379-C-T | Uncertain significance (May 09, 2023) | |||
18-49565400-C-G | Uncertain significance (Jun 27, 2022) | |||
18-49565423-C-T | Likely benign (Oct 28, 2023) | |||
18-49565437-C-T | Benign (Nov 15, 2023) | |||
18-49565448-T-C | Uncertain significance (Mar 02, 2023) | |||
18-49565490-G-A | Uncertain significance (Nov 23, 2022) | |||
18-49565506-C-T | Likely benign (Nov 28, 2023) | |||
18-49567426-C-G | Benign (Jan 24, 2024) | |||
18-49567444-G-T | Uncertain significance (May 18, 2022) | |||
18-49567447-C-T | Likely benign (Oct 20, 2023) | |||
18-49567453-C-T | Likely benign (Oct 18, 2023) | |||
18-49567478-G-A | Uncertain significance (May 25, 2022) | |||
18-49567490-C-T | not specified | Uncertain significance (Apr 27, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LIPG | protein_coding | protein_coding | ENST00000261292 | 10 | 32204 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.02e-10 | 0.295 | 125673 | 0 | 75 | 125748 | 0.000298 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.857 | 257 | 299 | 0.860 | 0.0000190 | 3319 |
Missense in Polyphen | 103 | 130.55 | 0.78895 | 1471 | ||
Synonymous | -1.20 | 134 | 117 | 1.14 | 0.00000808 | 945 |
Loss of Function | 0.907 | 18 | 22.7 | 0.794 | 0.00000116 | 267 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000206 | 0.000206 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.00208 | 0.00208 |
European (Non-Finnish) | 0.000132 | 0.000114 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.000229 | 0.000229 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Has phospholipase and triglyceride lipase activities. Hydrolyzes high density lipoproteins (HDL) more efficiently than other lipoproteins. Binds heparin.;
- Pathway
- Glycerolipid metabolism - Homo sapiens (human);Cholesterol metabolism - Homo sapiens (human);HDL remodeling;Transport of small molecules;Glycerophospholipid metabolism;triacylglycerol degradation;Plasma lipoprotein assembly, remodeling, and clearance;Plasma lipoprotein remodeling
(Consensus)
Recessive Scores
- pRec
- 0.336
Intolerance Scores
- loftool
- 0.249
- rvis_EVS
- 0.49
- rvis_percentile_EVS
- 79.46
Haploinsufficiency Scores
- pHI
- 0.180
- hipred
- Y
- hipred_score
- 0.615
- ghis
- 0.435
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.766
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Lipg
- Phenotype
- homeostasis/metabolism phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);
Gene ontology
- Biological process
- lipid metabolic process;response to nutrient;cell population proliferation;phospholipid catabolic process;positive regulation of high-density lipoprotein particle clearance;positive regulation of cholesterol transport;high-density lipoprotein particle remodeling;cholesterol homeostasis;reverse cholesterol transport;regulation of lipoprotein metabolic process;phospholipid homeostasis
- Cellular component
- extracellular region;extracellular space;early endosome;Golgi apparatus;cell surface
- Molecular function
- lipoprotein lipase activity;phospholipase activity;heparin binding;phospholipase A1 activity